Key Takeaways
- • BluePeak Private Capital Fund II achieved a first close of $80 million in May 2025, backed by four leading European Development Finance Institutions (BII, FMO, Swedfund, and SIFEM) committing $30 million, $15 million, $20 million, and $15 million respectively.
- • BPCF II is a pan-African impact-driven private credit fund targeting underserved mid-market businesses across manufacturing, pharmaceuticals, industrial packaging, logistics, and financial services sectors.
- • The fund launches less than four years after BluePeak Private Capital Fund I's close, demonstrating sustained institutional confidence in the firm's track record since its 2019 establishment.
- • BluePeak addresses a critical financing gap in Africa's mid-market segment, providing debt and equity growth capital to scalable businesses that have demonstrated viability but lack access to traditional funding sources.
- • The firm has previously backed leading regional platforms including Grit Real Estate Income Group, ieng Group, Africure Pharmaceuticals, and Watu Africa, establishing a demonstrated investment execution track record.
Summary
BluePeak Private Capital announced the first close of its second fund in May 2025, raising $80 million from institutional European development finance partners. The closing represents a significant commitment to growth-stage capital deployment across African mid-market businesses and validates the firm's investment thesis and operational performance since its founding in 2019.
The fund's investor syndicate reflects institutional-grade conviction: British International Investment (BII) committed $30 million, making it the lead institutional investor, while FMO (the Dutch Entrepreneurial Bank), Swedfund, and Swiss Investment Fund for Emerging Markets (SIFEM) each contributed $15 million, $20 million, and $15 million respectively. This concentrated backing from four major European Development Finance Institutions underscores the strategic priority placed on African SME financing by bilateral and multilateral development partners.
BluePeak Private Capital Fund II targets a critical market inefficiency: Africa's mid-market business segment remains significantly underfunded despite comprising viable, scalable enterprises. The fund deploys both debt and equity capital across strategic sectors including manufacturing, pharmaceuticals, industrial packaging, logistics, and financial services. This sector diversification mitigates concentration risk while maintaining focus on capital-intensive, essential industries with strong unit economics and regional demand drivers.
BluePeak's prior investment portfolio demonstrates execution capability across multiple asset classes and geographies. Portfolio companies include Grit Real Estate Income Group, ieng Group, Africure Pharmaceuticals, and Watu Africa—each representing different sector exposures and scaling trajectories. The relatively rapid fundraising cycle for Fund II (less than four years after Fund I's close) indicates that LPs view BluePeak's risk-adjusted return delivery and operational support capabilities as competitive within the African alternative capital landscape.
The fund's impact mandate—delivering superior risk-adjusted returns while generating measurable development outcomes—aligns with the investment mandates of its institutional backers, positioning BPCF II within the broader institutional capital reallocation toward emerging markets and impact-driven private credit strategies.
The fund's investor syndicate reflects institutional-grade conviction: British International Investment (BII) committed $30 million, making it the lead institutional investor, while FMO (the Dutch Entrepreneurial Bank), Swedfund, and Swiss Investment Fund for Emerging Markets (SIFEM) each contributed $15 million, $20 million, and $15 million respectively. This concentrated backing from four major European Development Finance Institutions underscores the strategic priority placed on African SME financing by bilateral and multilateral development partners.
BluePeak Private Capital Fund II targets a critical market inefficiency: Africa's mid-market business segment remains significantly underfunded despite comprising viable, scalable enterprises. The fund deploys both debt and equity capital across strategic sectors including manufacturing, pharmaceuticals, industrial packaging, logistics, and financial services. This sector diversification mitigates concentration risk while maintaining focus on capital-intensive, essential industries with strong unit economics and regional demand drivers.
BluePeak's prior investment portfolio demonstrates execution capability across multiple asset classes and geographies. Portfolio companies include Grit Real Estate Income Group, ieng Group, Africure Pharmaceuticals, and Watu Africa—each representing different sector exposures and scaling trajectories. The relatively rapid fundraising cycle for Fund II (less than four years after Fund I's close) indicates that LPs view BluePeak's risk-adjusted return delivery and operational support capabilities as competitive within the African alternative capital landscape.
The fund's impact mandate—delivering superior risk-adjusted returns while generating measurable development outcomes—aligns with the investment mandates of its institutional backers, positioning BPCF II within the broader institutional capital reallocation toward emerging markets and impact-driven private credit strategies.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.